Lotus Health Group Company (600186.SS)
CNY 5.31
(-1.67%)
CNY 5.31
(-1.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 74.02 Million | 54.96 Million | 70.04 Million | -794.22 Million | -95.91 Million | -24.09 Million |
| Net Income | 130.67 Million | 46.97 Million | 42.93 Million | 76.94 Million | 28.05 Million | -384.13 Million |
| Depreciation & Amortization | 18.09 Million | 18.29 Million | 11.35 Million | 11.41 Million | 25.65 Million | 38.94 Million |
| Deferred income taxes | 40.09 Million | 13.38 Million | 10.75 Million | 27.08 Million | 22.8 Million | -5.56 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -84.06 Million | -24.42 Million | -4.09 Million | -905.07 Million | 82.35 Million | 104.91 Million |
| Other non-cash items | 475.14 Thousand | 14.11 Million | 19.85 Million | 22.48 Million | -231.98 Million | 216.18 Million |
| Investing Cash Flow | -130.19 Million | -41.56 Million | -109.34 Million | -89.71 Million | 437.05 Million | 39.31 Million |
| Investments in PPE | -110.14 Million | -41.56 Million | -101.51 Million | -90.18 Million | -1.21 Million | -5.1 Million |
| Acquisitions | 24 Million | - | 1.36 Million | 915.1 Thousand | 438.27 Million | 44.42 Million |
| Investment purchases | -20.05 Million | - | -9 Million | - | - | - |
| Sales/Maturities of investments | - | - | -1.36 Million | - | - | - |
| Other Investing Activities | -20.04 Million | - | 1.17 Million | -450 Thousand | -0.16 | 44.42 Million |
| Financing Cash Flow | 96.69 Million | -26.57 Million | 605.65 Million | -125.07 Million | 674.98 Million | 8.14 Million |
| Debt repayment | -91.87 Million | -20 Million | -420 Million | -24 Million | -40.67 Million | -18 Million |
| Dividends payments | -438.63 Thousand | -5.01 Million | -19.82 Million | -20.58 Million | -19.76 Million | -9.85 Million |
| Common Stock Repurchased | -10.46 Million | -39.53 Million | -976.15 Million | - | - | - |
| Common Stock Issuance | 13.43 Million | 19.53 Million | 976.15 Million | - | - | - |
| Other Financing Activities | 5.25 Million | 18.43 Million | 1.04 Billion | -80.48 Million | 735.42 Million | 17.99 Million |
| Accounts receivables | 139.03 Million | -585.45 Thousand | 41.07 Million | -248.47 Million | 166.17 Million | -26 Million |
| Accounts payables | -197.87 Million | -54.44 Million | -86.53 Million | -641.23 Million | -144.71 Million | 145.58 Million |
| Inventory | -65.32 Million | 17.22 Million | 30.61 Million | -42.44 Million | 38.09 Million | -9.09 Million |
| Other working capital | -157.77 Million | 13.38 Million | 10.75 Million | 27.08 Million | 22.8 Million | 114.01 Million |
| Cash at beginning of period | 599.9 Million | 612.18 Million | 46.24 Million | 1.05 Billion | 39.42 Million | 16.06 Million |
| Cash at end of period | 640.49 Million | 599.9 Million | 612.18 Million | 46.24 Million | 1.05 Billion | 39.42 Million |
| Capital Expenditure | -110.14 Million | -41.56 Million | -101.51 Million | -90.18 Million | -1.21 Million | -5.1 Million |
| Effect of forex changes on cash | 62.09 Thousand | 902.83 Thousand | -416.97 Thousand | -300.88 Thousand | 283.37 | 975.08 |
| Net cash flow / Change in cash | 40.58 Million | -12.27 Million | 565.94 Million | -1 Billion | 1.01 Billion | 23.36 Million |
| Free Cash Flow | -36.12 Million | 13.39 Million | -31.46 Million | -884.41 Million | -97.12 Million | -29.2 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 64.3 Million | 51.61 Million | 49.22 Million | 33.02 Million | 130.67 Million | 44.43 Million |
| Depreciation & Amortization | - | 10.42 Million | 10.42 Million | 18.09 Million | 18.09 Million | -8.96 Million |
| Deferred income taxes | - | - | - | - | 40.09 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -22.88 Million | - | 73.71 Million | -84.06 Million | 43.79 Million |
| Other non-cash items | 4.49 Million | 22.13 Million | 125.7 Million | -33.02 Million | 475.14 Thousand | -35.06 Million |
| Investing Cash Flow | -249.45 Million | -169.95 Million | -198.15 Million | -86.37 Million | -130.19 Million | -31.86 Million |
| Investments in PPE | -250.7 Million | -175.01 Million | -198.23 Million | -86.24 Million | -110.14 Million | -11.81 Million |
| Acquisitions | - | - | - | 24 Million | 24 Million | - |
| Investment purchases | - | -70 Thousand | - | - | -20.05 Million | -20.05 Million |
| Sales/Maturities of investments | 15.05 Million | 5 Million | - | - | - | - |
| Other Investing Activities | -13.79 Million | 130 Thousand | 80 Thousand | -130 Thousand | -20.04 Million | -20.05 Million |
| Financing Cash Flow | 181.49 Million | 182.84 Million | 181.5 Million | 113.73 Million | 96.69 Million | -6.56 Million |
| Debt repayment | -186.95 Million | -190.8 Million | -184.56 Million | -111.87 Million | -91.87 Million | -20 Million |
| Dividends payments | -8.49 Million | -6.85 Million | -3.06 Million | -438.63 Thousand | -438.63 Thousand | - |
| Common Stock Repurchased | - | - | - | -13.43 Million | -10.46 Million | 10.46 Million |
| Common Stock Issuance | - | - | - | 13.43 Million | 13.43 Million | - |
| Other Financing Activities | 3.02 Million | -7.96 Million | -3.06 Million | 2.29 Million | 5.25 Million | 2.96 Million |
| Accounts receivables | - | -63.65 Million | - | 139.03 Million | 139.03 Million | 10.74 Million |
| Accounts payables | - | - | - | - | -197.87 Million | - |
| Inventory | - | 40.76 Million | - | -65.32 Million | -65.32 Million | 33.04 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 874.98 Million | 798.76 Million | 640.49 Million | 615.46 Million | 599.9 Million | 609.69 Million |
| Cash at end of period | 875.82 Million | 874.98 Million | 798.76 Million | 640.49 Million | 640.49 Million | 615.46 Million |
| Capital Expenditure | -250.7 Million | -175.01 Million | -198.23 Million | -86.24 Million | -110.14 Million | -11.81 Million |
| Effect of forex changes on cash | - | - | - | 62.09 Thousand | 62.09 Thousand | -0.61 |
| Net cash flow / Change in cash | 840.8 Thousand | 76.22 Million | 158.27 Million | 25.02 Million | 40.58 Million | 5.76 Million |
| Free Cash Flow | -181.91 Million | -111.68 Million | -23.31 Million | -88.63 Million | -36.12 Million | 32.38 Million |
9960
3909
COD
PMP
BEEF3
CLE